Chestnut Hill, Massachusetts Clinical Trials

A listing of Chestnut Hill, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 112 clinical trials
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
dulaglutide
body mass index
tirzepatide
Joslin Diabetes Center
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

olaparib
paclitaxel
carboplatin
recurrent disease
cancer
Research Site
 (5.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +94 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

paclitaxel
kaposi sarcoma
non-small cell carcinoma
carboplatin
stage iia lung cancer ajcc v7
Winchester Hospital
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +358 other locations
Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC

This trial is to investigate whether pre-pectoral Implant-Based Breast Reconstruction (IBBR) provides better Quality of Life (QoL) with respect to long-term (24 months) physical well-being (chest) compared to sub-pectoral IBBR for patients undergoing skin-sparing mastectomy or nipple-sparing mastectomy for prevention or treatment of breast cancer.

breast reconstruction
breast cancer
mastectomy
cancer
Brigham and Women's Hospital Harvard Medical School
 (4.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +20 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

alzheimer's disease
positron emission tomography
florbetapir
flortaucipir
mini-mental state examination
Boston Center for Memory
 (1.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

central nervous system disease
irinotecan
cancer
measurable disease
neutrophil count
Dana Farber Cancer Institute
 (3.8 away) Contact site
  • 8 views
  • 19 Feb, 2024
  • 1 location
Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

adenocarcinoma of prostate
androgen suppression
gonadotropin releasing hormone
luteinizing hormone
abiraterone
Dana Farber Cancer Institute
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

proteasome inhibitor
ixazomib
lenalidomide
daratumumab
measurable disease
Investigational Site Number 8400003
 (4.0 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +7 other locations
Test trial v7.2 (May 13) - Test 1 (Acro - Test 1)

Test trial v7.2 (May 13) - Test 1

US-Site 1
 (4.8 away) Contact site
  • 0 views
  • 13 May, 2025
  • +2 other locations
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …

Metro Boston Clinical Partners- Site Number : 8400008
 (2.1 away) Contact site
  • 0 views
  • 29 Nov, 2025
  • +30 other locations